Tag: Kiniksa Pharmaceuticals Ltd

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Kiniksa Pharmaceuticals Ltd

Vanguard Group Inc Has $14.18 Million Stake in Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

Added to Collection on: 2019-02-18 14:00:00

Tags for this article:

Money
Finance
Economy
Short
Pharmaceuticals policy
Pharmaceutical industry in China
Science and technology in the People's Republic of China
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Announces Data from US Investigator-Initiated Study of Mavrilimumab in Severe COVID-19 ...

Added to Collection on: 2020-12-22 12:56:15

Tags for this article:

Health sciences
Health
Clinical research
Design of experiments
Pharmaceutical industry
COVID-19 drug development
Remdesivir
Coronavirus disease
Mavrilimumab
Mechanical ventilation
Placebo-controlled study
Clinical trial
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
What Kind Of Investors Own Most Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)?

Added to Collection on: 2021-01-02 14:26:15

Tags for this article:

Finance
Money
Financial markets
Stock market
Corporate finance
Equity securities
Alternative investment management companies
Hedge fund
Stock
Common stock
Institutional investor
Short
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Brokers Set Expectations for Kiniksa Pharmaceuticals, Ltd.'s Q1 2022 Earnings (NASDAQ:KNSA)

Added to Collection on: 2021-02-25 13:30:00

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Equity securities
Corporate finance
Stock
Share
Price?earnings ratio
Reverse stock split
Short
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Pharmaceuticals Ltd. (KNSA) – Don't Be So Quick to Call it Dead

Added to Collection on: 2021-03-19 21:45:00

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Stock
Short
NASDAQ
Volume
Insider trading
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
-$0.74 Earnings Per Share Expected for Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) This Quarter

Added to Collection on: 2021-04-24 08:48:45

Tags for this article:

Financial markets
Finance
Money
Stock market
Corporate finance
Price?earnings ratio
Short
Financial ratio
Stock
Market capitalization
Stock valuation
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Pharmaceuticals to Present at Goldman Sachs 42nd Annual Global Healthcare Conference

Added to Collection on: 2021-06-01 21:00:00

Tags for this article:

Life Sciences
Health sciences
Pharmaceutical industry
Biotechnology
Regeneron Pharmaceuticals
Rilonacept
Biopharmaceutical
Medication
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D ...

Added to Collection on: 2021-10-07 12:22:30

Tags for this article:

Life Sciences
Companies
Biotechnology companies
Economy of New York City
NASDAQ
Amgen
MorphoSys
Vertex Pharmaceuticals
Pluristem Therapeutics
PTC Therapeutics
ensysce biosciences, inc.
DURECT Corporation
Indaptus Therapeutics Inc.
Aziyo Biologics Inc.
eiger biopharmaceuticals inc
Minerva Neurosciences Inc
Aytu BioPharma Inc.
Orphazyme A/S
ROCKWELL MEDICAL , INC
Glaukos Corporation
Heron Therapeutics Inc
Longeveron Inc.
HCW Biologics Inc.
Catalyst Pharmaceuticals Inc
Hoth Therapeutics Inc.
DICE Therapeutics, Inc.
TELIGENT , INC
Aptinyx Inc.
Nuwellis Inc.
Adverum Biotechnologies Inc.
BiondVax Pharmaceuticals Ltd.
Spruce Biosciences Inc.
Mesoblast Limited
Chemomab Therapeutics, Ltd.
Kiniksa Pharmaceuticals Ltd
trevi therapeutics, inc.
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
China SXT Pharmaceuticals Inc.
Amgen Inc.
POINT Biopharma Global Inc.
TCR2 Therapeutics Inc.
Pluristem Therapeutics Inc.
Forte Biosciences Inc.
Vertex Pharmaceuticals Incorporated
Oncorus Inc.
Year Moderna, Inc.
Acutus Medical Inc.
Neovasc Inc.
Spectrum Pharmaceuticals Inc.
Oyster Point Pharma Inc.
Incyte Corporation
Moleculin Biotech Inc.
Nautilus Biotechnology Inc.
Caladrius Biosciences Inc.
MORPHOSYS AG
Inhibikase Therapeutics Inc.
Galecto Inc.
MaxCyte Inc.
Immunic Inc
Kiromic BioPharma Inc.
Cellectis SA
Gamida Cell Ltd
BioSig Technologies Inc.
LumiraDx Limited
NRx Pharmaceuticals, Inc.
Stoke Therapeutics Inc
histogen inc
Calliditas Therapeutics AB
PTC Therapeutics Inc.
Solid Biosciences Inc.
Aravive Inc
Titan Pharmaceuticals Inc.
Roivant Sciences Ltd.
Liminal BioSciences Inc.
Akoya Biosciences Inc.
Kaleido Biosciences Inc.
Applied Genetic Technologies Corporation
Moderna
Assertio Holdings Inc.
Talis Biomedical Corporation
Sangamo Therapeutics Inc.
Lixte Biotechnology Holdings Inc.
Petros Pharmaceuticals Inc.
KALA PHARMACEUTICALS, INC
XBiotech Inc.
Orchard Therapeutics plc
Legend Biotech Corporation
Galapagos NV
Angion Biomedica Corp
Applied Dna Sciences Inc.
Esperion Therapeutics Inc.
Imara Inc.
Enanta Pharmaceuticals Inc.
Harpoon Therapeutics Inc.
Graphite Bio Inc.
Tiziana Life Sciences PLC
BioVie Inc
Applied Molecular Transport Inc.
Viveve Medical Inc.
Immuron Limited
Protara Therapeutics Inc.
4d molecular therapeutics
HOOKIPA Pharma Inc.
Pasithea Therapeutics Corp.
CASI PHARMACEUTICALS , INC
InMed Pharmaceuticals Inc.
Gain Therapeutics Inc.
NeuroBo Pharmaceuticals Inc.
Opiant Pharmaceuticals Inc
Lipocine Inc

Click the tags to see associated articles and topics

View Article Details
Kinksa Pharmaceuticals stock tumbles after treatment of COVID-related ARDS disappoints ...

Added to Collection on: 2021-12-28 12:52:02

Tags for this article:

Medical specialties
Monoclonal antibodies
Mavrilimumab
Clinical medicine
Acute respiratory distress syndrome
Medicine
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Down 3.8% - ETF Daily News

Added to Collection on: 2022-06-26 08:30:03

Tags for this article:

Life Sciences
Financial regulation
Short
Industry economics)
Biotechnology
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details